Rohit Aggarwal MD
Assistant Professor, Medicine, University of Pittsburgh School of Medicine
Join to View Full Profile
3601 5th AveSuite 3B Falk Medical BuildingPittsburgh, PA 15213
Phone+1 412-647-6700
Dr. Aggarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rush University Medical CenterFellowship, Rheumatology, 2007 - 2009
UPMC Medical EducationResidency, Internal Medicine, 2004 - 2007
Delhi University College of Medical SciencesClass of 2003
Certifications & Licensure
FL State Medical License 2023 - Present
ME State Medical License Current
PA State Medical License 2004 - 2026
IL State Medical License 2007 - 2011
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification MyUPMC, UPMC, 2012-2017
- CMS Meaningful Use Stage 2 Certification MyUPMC, UPMC, 2012-2017
Clinical Trials
- Acthar in Treatment of Refractory Dermatomyositis and Polymyositis Start of enrollment: 2013 Sep 01
- Predictor of Clinical Response to Acthar in Myositis Start of enrollment: 2017 Nov 06
Publications & Presentations
PubMed
- Nomenclature and abbreviation heterogeneity in immune-mediated necrotizing myopathy: A call for standardization.Maha Almackenzie, Niladri Bhowmick, Ganeev Bhangoo, Anushka Aggarwal, Tanya Chandra
Seminars in Arthritis and Rheumatism. 2026-04-01 - A Phase 3 Trial of Brepocitinib in Dermatomyositis.Ruth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, Aaron R Mangold, Prateek C Gandiga
The New England Journal of Medicine. 2026-03-28 - Prognostic significance of 1-year pulmonary function changes in inflammatory myopathy-related interstitial lung disease.Shiri Keret, Silvia Martinez Laverde, Raisa Lomanto Silva, Irada Choudhuri, Eugenia Gkiaouraki
Seminars in Arthritis and Rheumatism. 2026-03-11
Journal Articles
- Author Correction: Treatment in MyositisChester V Oddis, Rohit Aggarwal, Nature
Lectures
- Autoantibodies Predict Treatment Response to Rituximab in Myositis76th Annual Scienific Meeting, Washington, DC, USA
- Autoantibodies Predict Treatment Response to Rituximab in MyositisAmerican College of Rheumatology, 76th Annual Scienific Meeting, Washington, DC, USA
Other
- Dupuytren's contractureAggarwal R, Anderson BC
http://www.uptodate.com/contents/dupuytrens-contracture
UpToDate, Wolters Kluwer Health - 2012-12-05 - de Quervain's tenosynovitisAggarwal R, Anderson BC
http://www.uptodate.com/contents/de-quervains-tenosynovitis
UpToDate, Wolters Kluwer Health - 2012-07-03 - Sarcoid arthropathyAggarwal R, Sequeira W
http://www.uptodate.com/contents/sarcoid-arthropathy
UpToDate, Wolters Kluwer Health - 2012-03-28
Press Mentions
Management of Challenging Cases in MyositisOctober 31st, 2025- Abatacept Shows Promise for Some Myositis PatientsMay 12th, 2025
- CT Results in Myositis Inform Cancer Screening StrategiesMarch 24th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
